PH12016500683B1 - Synthetic route to 2`-deoxy-2`,2`-difluorotetrahydrouridines - Google Patents

Synthetic route to 2`-deoxy-2`,2`-difluorotetrahydrouridines

Info

Publication number
PH12016500683B1
PH12016500683B1 PH12016500683A PH12016500683A PH12016500683B1 PH 12016500683 B1 PH12016500683 B1 PH 12016500683B1 PH 12016500683 A PH12016500683 A PH 12016500683A PH 12016500683 A PH12016500683 A PH 12016500683A PH 12016500683 B1 PH12016500683 B1 PH 12016500683B1
Authority
PH
Philippines
Prior art keywords
deoxy
difluorotetrahydrouridines
synthetic route
intermediates
synthesizing
Prior art date
Application number
PH12016500683A
Other languages
English (en)
Other versions
PH12016500683A1 (en
Inventor
Hyeong-Wook Choi
Steven Mathieu
Frank Fang
Bryan Matthew Lewis
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of PH12016500683A1 publication Critical patent/PH12016500683A1/en
Publication of PH12016500683B1 publication Critical patent/PH12016500683B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0201Oxygen-containing compounds
    • B01J31/0209Esters of carboxylic or carbonic acids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0235Nitrogen containing compounds
    • B01J31/0237Amines
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0235Nitrogen containing compounds
    • B01J31/0244Nitrogen containing compounds with nitrogen contained as ring member in aromatic compounds or moieties, e.g. pyridine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH12016500683A 2013-10-29 2016-04-13 Synthetic route to 2`-deoxy-2`,2`-difluorotetrahydrouridines PH12016500683B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361896703P 2013-10-29 2013-10-29
PCT/US2014/062874 WO2015066162A1 (en) 2013-10-29 2014-10-29 Synthetic route to 2'-deoxy-2',2'-difluorotetrahydrouridines

Publications (2)

Publication Number Publication Date
PH12016500683A1 PH12016500683A1 (en) 2016-05-30
PH12016500683B1 true PH12016500683B1 (en) 2020-02-14

Family

ID=51982743

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12016500683A PH12016500683B1 (en) 2013-10-29 2016-04-13 Synthetic route to 2`-deoxy-2`,2`-difluorotetrahydrouridines

Country Status (19)

Country Link
US (3) US9834576B2 (https=)
EP (1) EP3063164B1 (https=)
JP (1) JP6427567B2 (https=)
KR (1) KR102272773B1 (https=)
CN (1) CN105683209B (https=)
AU (1) AU2014342402B2 (https=)
BR (1) BR112016008855B1 (https=)
CA (1) CA2926734C (https=)
ES (1) ES2712877T3 (https=)
IL (1) IL244849B (https=)
MX (1) MX363205B (https=)
MY (1) MY176465A (https=)
NZ (1) NZ718607A (https=)
PH (1) PH12016500683B1 (https=)
RU (1) RU2681939C2 (https=)
SA (1) SA516371019B1 (https=)
SG (1) SG11201602614XA (https=)
WO (1) WO2015066162A1 (https=)
ZA (1) ZA201602315B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2681939C2 (ru) 2013-10-29 2019-03-14 Оцука Фармасьютикал Ко., Лтд. Путь синтезирования 2'-дезокси-2'2'-дифтортетрагидроуридинов
US11224610B2 (en) 2018-09-19 2022-01-18 Otsuka Pharmaceutical Co., Ltd. Low dose combination CDA substrate drug/cedazuridine with extended administration
PH12022550795A1 (en) * 2019-10-08 2023-09-25 Otsuka Pharma Co Ltd 2`-deoxy-2`,2`-difluorotetrahydrouridines with high purity and methods of making the same
PH12022552250A1 (en) 2020-02-25 2023-11-13 Otsuka Pharma Co Ltd Combination decitabine and cedazuridine solid oral dosage forms
KR20230043904A (ko) 2020-07-24 2023-03-31 엘랑코 유에스 인코포레이티드 이속사졸린 화합물 및 이의 중간체의 제조 공정
CN113402573B (zh) * 2020-07-31 2023-06-20 集美大学 一种鞣质类化合物及其提取方法和应用
CN116744917A (zh) 2020-09-04 2023-09-12 礼蓝美国公司 适口调配物
WO2022254457A1 (en) * 2021-05-29 2022-12-08 Msn Laboratories Private Limited, R&D Center An improved process for the preparation of (4r)-1-[(2r,4r,5r)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl) oxolan-2-yl]-4-hydroxy-1,3-diazinan-2one and its intermediate compounds
TWI821074B (zh) * 2021-12-25 2023-11-01 台灣神隆股份有限公司 製備希達路里定(cedazuridine)的方法
US20230271996A1 (en) * 2021-12-25 2023-08-31 Scinopharm Taiwan, Ltd. Process for preparing cedazuridine

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4965374A (en) 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
US5223608A (en) 1987-08-28 1993-06-29 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
FR2682112B1 (fr) 1991-10-08 1993-12-10 Commissariat A Energie Atomique Procede de synthese d'acide ribonucleique (arn) utilisant un nouveau reactif de deprotection.
US5371210A (en) 1992-06-22 1994-12-06 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5521294A (en) 1995-01-18 1996-05-28 Eli Lilly And Company 2,2-difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides
US6001994A (en) 1995-12-13 1999-12-14 Eli Lilly And Company Process for making gemcitabine hydrochloride
KR19990076695A (ko) 1995-12-22 1999-10-15 리차드 알. 이킨 시티딘 데아미나제 혹은 데옥시시티딘 데아미나제의 과발현과연관된 질병들을 치료하기 위한 활성제_및 방법
US5760208A (en) 1996-08-14 1998-06-02 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Process to prepare pyrimidine nucleosides
DE60144573D1 (de) 2000-11-29 2011-06-16 Mitsui Chemicals Inc Verfahren und Zwischenprodukte bei der Synthese von L-Thymidin
FI112640B (fi) 2000-12-22 2003-12-31 Kone Corp Hissin turvalaite
KR101108407B1 (ko) * 2006-06-21 2012-01-30 일라이 릴리 앤드 캄파니 젬시타빈 아미드 전구약물의 결정 형태, 그의 조성물 및 용도
JO2778B1 (en) * 2007-10-16 2014-03-15 ايساي انك Certain Compounds, Compositions and Methods
RU2681939C2 (ru) 2013-10-29 2019-03-14 Оцука Фармасьютикал Ко., Лтд. Путь синтезирования 2'-дезокси-2'2'-дифтортетрагидроуридинов

Also Published As

Publication number Publication date
SG11201602614XA (en) 2016-05-30
US10526362B2 (en) 2020-01-07
US9834576B2 (en) 2017-12-05
US20200123189A1 (en) 2020-04-23
ZA201602315B (en) 2019-07-31
MY176465A (en) 2020-08-11
RU2681939C2 (ru) 2019-03-14
BR112016008855A2 (https=) 2017-08-01
IL244849A0 (en) 2016-05-31
RU2016115523A3 (https=) 2018-06-05
US11028119B2 (en) 2021-06-08
KR102272773B1 (ko) 2021-07-02
AU2014342402A1 (en) 2016-04-21
CA2926734A1 (en) 2015-05-07
JP6427567B2 (ja) 2018-11-21
EP3063164A1 (en) 2016-09-07
EP3063164B1 (en) 2018-12-05
WO2015066162A1 (en) 2015-05-07
US20160237107A1 (en) 2016-08-18
RU2016115523A (ru) 2017-12-04
JP2017500281A (ja) 2017-01-05
KR20160083021A (ko) 2016-07-11
US20180072768A1 (en) 2018-03-15
BR112016008855B1 (pt) 2023-01-17
SA516371019B1 (ar) 2018-01-23
ES2712877T3 (es) 2019-05-16
IL244849B (en) 2019-10-31
CA2926734C (en) 2022-03-15
AU2014342402B2 (en) 2018-11-01
MX363205B (es) 2019-03-13
HK1223627A1 (en) 2017-08-04
CN105683209A (zh) 2016-06-15
CN105683209B (zh) 2019-03-08
MX2016005596A (es) 2016-12-09
PH12016500683A1 (en) 2016-05-30
NZ718607A (en) 2019-10-25

Similar Documents

Publication Publication Date Title
PH12016500683A1 (en) Synthetic route to 2`-deoxy-2`,2`-difluorotetrahydrouridines
MX2020009649A (es) Anticuerpos monoclonales contra bcma.
PH12016501763B1 (en) Multispecific antibodies
MY184733A (en) Pyrimidine fgfr4 inhibitors
EA201591750A1 (ru) Антитела против b7-h4 и иммуноконъюгаты
UY34824A (es) Nucleósidos de espirooxetano de uracilo
UY34817A (es) Tienopirimidinas
ZA201703510B (en) Antibodies, uses & methods
MX345926B (es) Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas.
PH12015502665A1 (en) Improvements in or relating to organic compounds
UY34553A (es) Procedimiento de preparación de la sal de l-arginina de perindoprilo
IN2014DN06738A (https=)
NZ720106A (en) A process for the preparation of regadenoson
EA201690263A1 (ru) Улучшенные способы получения перампанеля
PH12016501201A1 (en) Synthesis of ent-progesterone and intermediates thereof
PH12016501326A1 (en) (s)-3'-methyl-abscisic acid and esters thereof
PH12016502592A1 (en) 3'-substituted-abscisic acid derivatives
MX2016000487A (es) Piridina-2-carboxamidas como nematicidas.
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
MX2016005511A (es) Intermediarios y metodos para sintetizar derivados de calicheamicina.
MX2015012902A (es) Sintesis de ent-progesterona e intermediarios de la misma.
IN2013MU04030A (https=)
IN2013CH00453A (https=)
UA91886U (uk) 1-трет-бутокси-3-(2,2,6,6-тетраметил-4-гідроксипіперидино)-2-пропанол
IN2013CH05395A (https=)